ArticleHead & face medicine2026
Exploring patient-reported outcomes after lacrimal surgery in a large monocentric cohort: cross-cultural adaptation of the Italian Lac-Q.
Article in Head & face medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Defining success in lacrimal drainage surgery: the case for a core outcome set.Eye (London, England) · 2026Article
- Comparison of the Impact of Different Dacryocystorhinostomy Techniques on Patient Quality of Life in Lacrimal Duct Obstruction.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo translate in Italian and revalidate the Lacrimal Symptom Questionnaire (Lac-Q), a symptom-based patient-reported outcome measure (PROM) for patients undergoing dacryocystorhinostomy (DCR) for nasolacrimal duct obstruction (NDO). The original English Lac-Q was validated on 17 patients; this study expands its evaluation to a substantially larger cohort.
methodsThe Lac-Q was translated and back-translated following standardized cross-cultural adaptation guidelines. A prospective cohort of adult patients with symptomatic NDO scheduled for DCR was recruited. Participants completed the Italian Lac-Q pre- and postoperatively, along with the Munk score, the Global Rating of Change Scale (GRS), the Brief Illness Perception Questionnaire (B-IPQ), and the Hospital Anxiety and Depression Scale (HADS). The Functional Endoscopic Dye Test (FEDT) was used as an objective measure of rhinostomy patency. Internal consistency, test–retest reliability, construct validity, and responsiveness were assessed. Anchor- and distribution-based methods were applied to calculate the Minimal Clinically Important Difference (MCID).
resultsA total of 124 subjects (97 females, mean age 62.6 ± 13.4 years) were included. The Italian Lac-Q demonstrated good internal consistency (Cronbach’s α > 0.7) and strong test–retest reliability (ICC = 0.94). Significant correlations were found with other PROMs and the FEDT, confirming construct validity. Responsiveness was adequate, with both symptom and social impact scores improving significantly after surgery. Patients achieving the estimated MCID aligned with those attaining surgical success.
conclusionsThe Italian Lac-Q is a reliable, valid, and responsive PROM for assessing symptoms and quality-of-life impact in patients with NDO, and represents a robust tool for evaluating outcomes in lacrimal surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.